Activity of aqueous ethanol extract of Euphorbia prostrata ait on Shigella dysenteriae type 1-induced diarrhea in rats

Indian Journal of Pharmacology

Volumn 39, Issue 5, 2007, Pages 240-244

  Rene, Kamgang ^a   Hortense, Gonsu ^a   Pascal, Wafo ^a   Jean Alexis, Mbungni ^a   Vidal, Pouokam ^a   Michel Archange, Fokam ^a   Christine, Fonkoua ^b  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b CENTRE PASTEUR DU CAMEROUN   (Cameroon)

Author keywords

Antidiarrheic activity; Euphorbia prostrate; Rat; Shigella dysenteriae type 1

Indexed keywords

ALCOHOL; ANTIDIARRHEAL AGENT; EUPHORBIA PROSTRATA EXTRACT; NORFLOXACIN;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DEFECATION; DIARRHEA; DRUG ACTIVITY; DRUG DOSE INCREASE; DRUG EFFECT; FECES; FEMALE; GASTROINTESTINAL MOTILITY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MOUSE; NONHUMAN; RAT; SHIGELLA DYSENTERIAE; SHIGELLOSIS;

EID: 36849022745     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: 10.4103/0253-7613.37275     Document Type: Article

References (35)

1. Sur D, Ramamurthy T, Deen J, Bhattacharya SK. Shigellosis: Challenges and management issues. Indian J Med Res 2004;120:454-62.
2. Dutta S, Dutta D, Dutta P, Matsushita S, Bhattacharya SK, Yoshida SI. Shigella dysenteriae serotype 1, Kolkatta, India. Emerg Infect Dis 2003;9:1471-4.
3. Naheed A, Kalluri P, Talukder KA, Faruque AS, Khatun F, Nair GB, et al. Fluoroquinolone-resistant Shigella dysenteriae type 1 in north-eastern Bangladesh. Lancet Infect Dis 2004;4:607-8.
4. Sivapalasingam S, Nelson JM, Joyce K, Hoekstra M, Angulo FJ, Mintz ED. High Prevalence of Antimicrobial Resistance among Shigella Isolates in the United States Tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002. Antimicrob Agents Chemother 2006;50:49-54.
5. Dutta S, Ghosh A, Ghosh K, Dutta D, Bhattacharya SK, Nair GB, et al. Newly emerged multiple antibiotic-resistant Shigella dysenteriae type 1 strains in and around Kolkatta, India, are clonal. J Clin Microbiol 2003;41:5833-4.
6. Dutta S, Kawamura Y, Ezaki T, Nair GB, Iida KI, Yoshida SI. Alteration in the GyrA submit of DNA gyrase and the ParC submit of topoisomerase IV in Quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkatta, India. Antimicrob Agents Chemother 2005;49:1660-1.
7. Pazhani GP, Sarkar B, Ramamurthy T, Bhattacharya SK, Takeda Y, Niyogi SK. Clonal multidrug-resistant Shigella dysenteriae type 1 strains associated with epidemic and sporadic dysenteries in eastern India. Antimicrob Agents Chemother 2004;48:681-4.
8. Ndihokubwayo JB, Baribwira C, Ndayiragije A, Poste B. Antibiotic sensitivity of 299 strains of shigella isolated in Burundi. Med Trop (Mars) 1996;56:37-40.
9. Cunin P, Tedjouka E, Germani Y, Ncharre C, Bercion R, Morvan J, et al. An epidemic of bloody diarrhea: Escherichia coli O157 emerging in Cameroon? Emerg Infect Dis 1999;5:285-90.
10. Tarnagda Z, Diagbouga S, Sankara P, Kienou K, Yaro S, Van De Pierre P. Sensitivity to antibiotics strains of Shigella dysenteriae type 1 implicated in an outbreak in Burkina Faso. Medicine d'Afrique Noire 2001;48:141-4.
11. Mshana NR, Abbiw DK, Addae-Mensah I, Adjanohoun JE, Ahyimira, Ekpere JA, Enow-Orock EG, et al. Traditional Medecine and pharmacopoeia contribution to the revision of ethnobotanical and floristic studies in Ghana Organisation of African. Unity/Scientific, Technical and Research Commission 2000. p. 243.
12. Tona L, Kambu K, Mesia K, Cimanga K, Apers S, De Bruyne T, et al. Biological screening of traditional preparations from some medicinal plants used as antidiarrheal in Kinshasa, Congo. Phytomedicine 1999;6:59-66.
13. Singla AK, Pathak K. Anti-inflammatory studies on Euphorbia prostrata. J Ethnopharmacol 1989;27:55-61.
14. Singla AK, Pathak K. Topical antiinflammatory effects of Euphorbia prostrata on carrageenan-induced footpad oedema in mice. J Ethnopharmacol 1990;29:291-4.
15. Kamgang R, Pouokam KE, Fonkoua MC, Penlap NB, Biwolé SM. Shigella dysenteriae type 1-induced diarrhea in Rats. Jpn J Infect Dis 2005;58:335-7.
16. 1-induced diarrhea in Rats. Clin Exp Pharmacol Physiol 2006;33:89-94.
17. Molle J. Limites de tolérence et toxicités de quelques amino-acides (formes L et D). Amino-peptides-protéine, Cahier 24; Ed. A.E.C. 1986. p. 207-32.
18. Odebiyi OO, Sofowora EA. Phytochemical screening of Nigerian medicinal plants. Lloydia 1978;41:234-46.
19. Orech FO, Akenga T, Ochora J, Friis H, Aagaard-Hansen J. Potential toxicity of some traditional leafy vegetables consumed in Nyanǵoma Division, Western Kenya. Afr J Food Nutr Sc (AJFAND) 2005;5:1-13.
20. National Committee of Clinical and Laboratory Standards. Performance standards for antimicrobial susceptibility testing: fifteenth informational supplement. CLSI/ NCCLS Document M100-S15. Clinical and Laboratory Standards Institute: Wayne, Pa; 2005
21. Carbonnelle B, Denis F, Marmonier A, Pinon G, Vargues R. Bactériologies Médicales Techniques Usuelles. Simep: Paris; 1987.
22. Islam MS, Hossain MZ, Khan SI, Felsenstein A, Sack RB, Albert MJ. Detection of non-culturable Shigella dysenteriae 1 from artificially contaminated volunteers' fingers using fluorescent antibody and PCR techniques. J Diarrhoeal Dis Res 1997;15:65-70.
23. Fish JT, Pettibone GW. Influence of freshwater sediment on the survival of Escherichia coli and Salmonella sp. as measured by three methods of enumeration. Lett Appl Microbiol 1995;20:277-81.
24. Patnaik GK, Banaudha KK, Khan KA, Shoeb A, Dhawan BN. Spasmotytic activity of angelicin from Heracleum thomsoni. Planta Med 1987;53:517-20.
25. nd ed. Slatkine, Genève: Paris; 1992. p. 33-5.
26. Iwalokun BA, Gbenle GO, Adewole TA, Akinsinde KA. Shigellocidal properties of three Nigerian medicinal plants: Ocimum gratissimum, Terminalia avicennoides and Mormodica balsamina. J Health Popul Nutr 2001;19:331-5.
27. Carre D, Chapalain JC, Debonne JM, Klotz F. Diarrhées infectieuses aiguës. Encycl. Med. Chir, Maladies infectieuses, 8-003-V-10, 2000. p. 16.
28. Cooke C, Carr I, Abrams K, Mayberry J. Arrowroot as a treatment for diarrhea in irritable bowel syndrome patients: A pilot study. Arq Gastroenterol 2000;37:20-4.
29. - secretion in intestinal epithelial T84 cells. Gastroenterology 2001;120:89-98.
30. Ludwig K, Karmali MA, Smith CR, Petric M. Cross-protection against challenge by intravenous Escherichia coli verocytotoxin 1 (VT1) in rabbits immunized with VT2 toxoid. Can J Microbiol 2002;48:99-103.
31. Di Carlo G, Autore G, Izzo AA, Maiolino P, Mascolo N, Viola P, et al. Inhibition of intestinal motility and secretion by flavonoids in mice and rats: Structure-activity relationships. J Pharm Pharmacol 1993;45:1054-9.
32. Balter-Seri J, Yuhas Y, Weizman A, Notech-Mozes Y, Kaminsky E, Ashkenazi S. Role of nitric oxide in the enhancement of pentylenetetrazole-induced seizures caused by Shigella dysenteriae. Infect Immun 1999;67:6364-8.
33. Camuesco D, Comalada M, Rodriguez-Cabezas ME, Nieto A, Lorente MD, Concha A, et al. The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression. Br J Pharmacol 2004;143:908-18.
34. th ed. Simep: Paris; 1996.
35. th ed. Flammarion Médecine-Sciences: Paris; 1993.